Publications found:
73,128
Sort by:
Otitis Media - Pipeline Review, H1 2020
US$ 2,000.00
... . The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
78 pages
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
107 pages
Urinary Incontinence - Pipeline Review, H1 2020
US$ 2,000.00
... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
74 pages
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Venous Leg Ulcers (Crural ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
68 pages
Alopecia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
190 pages
Colitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
121 pages
Diarrhea - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
153 pages
Fatigue - Pipeline Review, H1 2020
US$ 2,000.00
... . The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
39 pages
Tourette Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
86 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
197 pages
Alcohol Addiction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
183 pages
Ischemia Reperfusion Injury - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
177 pages
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Systemic Sclerosis (Scleroderma) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Sclerosis (Scleroderma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
374 pages
Traumatic Brain Injury - Pipeline Review, H1 2020
US$ 2,000.00
... . The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
414 pages
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Traumatic Stress Disorder (PTSD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
178 pages
Secondary Hyperparathyroidism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Secondary Hyperparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Secondary Hyperparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
61 pages
House Dust Mite Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The House Dust Mite Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
58 pages
Iron Deficiency Anemia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Iron Deficiency Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Iron Deficiency Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
95 pages
Sedation - Pipeline Review, H1 2020
US$ 2,000.00
... . The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
56 pages
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2020
US$ 2,000.00
... Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
87 pages
Intermittent Claudication - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Intermittent Claudication - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Intermittent Claudication (Cardiovascular), complete with analysis by stage of development ...
January 2020
55 pages
Myasthenia Gravis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myasthenia Gravis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Myasthenia Gravis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
207 pages
Obsessive-Compulsive Disorder - Pipeline Review, H1 2020
US$ 2,000.00
... . The Obsessive-Compulsive Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
58 pages
Post-Operative Pain - Pipeline Review, H1 2020
US$ 2,000.00
... . The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
295 pages
Dilated Cardiomyopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
58 pages
Left Ventricular Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
49 pages
Nasopharyngitis (Common Cold) - Pipeline Review, H1 2020
US$ 2,000.00
... Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
42 pages
Nocturia - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nocturia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
46 pages
Hepatic Encephalopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatic Encephalopathy (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Hepatic Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
89 pages
Primary Sclerosing Cholangitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Primary Sclerosing Cholangitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Sclerosing Cholangitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
128 pages
Restless Legs Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
61 pages
Hyperalgesia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hyperalgesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Hyperalgesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
39 pages
Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prader-Willi Syndrome (PWS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
104 pages
Thromboembolism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Thromboembolism (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Thromboembolism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
127 pages
Birch Pollen Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Birch Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
40 pages
Hidradenitis Suppurativa - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hidradenitis Suppurativa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Hidradenitis Suppurativa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
216 pages
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
1034 pages
Global Adult Milk Powder Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
US$ 3,480.00
... display the global Adult Milk Powder market. Chapter 1, to describe Adult Milk Powder Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Adult Milk Powder, with ...
January 2020
136 pages
Global Bacterial Vaginosis Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
US$ 3,480.00
... display the global Bacterial Vaginosis Drugs market. Chapter 1, to describe Bacterial Vaginosis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Bacterial Vaginosis Drugs, with ...
January 2020
130 pages
Acyl CoA Desaturase - Pipeline Review, H1 2020
US$ 3,500.00
Acyl CoA Desaturase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Acyl CoA Desaturase - Pipeline Review, H1 2020'; Acyl CoA Desaturase (Fatty Acid Desaturase or Delt...
January 2020
51 pages
Beta Nerve Growth Factor - Pipeline Review, H1 2020
US$ 3,500.00
Beta Nerve Growth Factor - Pipeline Review, H1 2020 SUMMARY Beta Nerve Growth Factor (Beta NGF or NGF) - Nerve growth factor is a neurotrophic factor involved in the regulation of growth, maintenanc...
January 2020
57 pages
Beta Secretase 1 - Pipeline Review, H1 2020
US$ 3,500.00
Beta Secretase 1 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Beta Secretase 1 - Pipeline Review, H1 2020'; Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amylo...
January 2020
34 pages
Caspase 3 - Pipeline Review, H1 2020
US$ 3,500.00
Caspase 3 - Pipeline Review, H1 2020 SUMMARY Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to...
January 2020
74 pages
Cyclin Dependent Kinase 4 - Pipeline Review, H1 2020
US$ 3,500.00
Cyclin Dependent Kinase 4 - Pipeline Review, H1 2020 SUMMARY Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) pipeline Target constitutes close to 32 mole...
January 2020
169 pages
Cyclin Dependent Kinase 9 - Pipeline Review, H1 2020
US$ 3,500.00
Cyclin Dependent Kinase 9 - Pipeline Review, H1 2020 SUMMARY Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell...
January 2020
118 pages
Hepcidin - Pipeline Review, H1 2020
US$ 3,500.00
Hepcidin - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Hepcidin - Pipeline Review, H1 2020'; Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumo...
January 2020
44 pages
